T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
ImmunityBio
IBRX
$7.91B
| $1.77M | ﹤0.01% |
182,102
-32,906
| -15% | -$362K |
|
|
CIM
1777
Chimera Investment
CIM
$999M
| $1.77M | ﹤0.01% |
39,766
-8,234
| -17% | -$369K |
|
1778
Navient
NAVI
$850M
| $1.77M | ﹤0.01% |
89,737
-37,200
| -29% | -$799K |
|
1779
Editas Medicine
EDIT
$419M
| $1.76M | ﹤0.01% |
42,968
+4,324
| +11% | +$237K |
|
1780
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $1.76M | ﹤0.01% |
6,013
| – | – |
|
1781
Carlyle Group
CG
$18.1B
| $1.76M | ﹤0.01% |
37,225
-1,466
| -4% | -$70.3K |
|
|
CEI
1782
DELISTED
Camber Energy, Inc
CEI
| $1.76M | ﹤0.01% |
9,217
+5,711
| +163% | +$257K |
|
|
LPRO
1783
DELISTED
Open Lending Corp
LPRO
| $1.76M | ﹤0.01% |
48,759
-525,795
| -92% | -$20.1M |
|
1784
Erie Indemnity
ERIE
$13.3B
| $1.75M | ﹤0.01% |
9,822
+56
| +0.6% | +$10.1K |
|
1785
Graham Holdings Company
GHC
$4.98B
| $1.74M | ﹤0.01% |
2,957
-99
| -3% | -$61.7K |
|
1786
PUT
Alcoa
AA
$13.2B
| $1.74M | ﹤0.01% |
35,000
+13,500
| +63% | +$570K |
|
1787
Resideo Technologies
REZI
$3.13B
| $1.74M | ﹤0.01% |
70,019
-1,570,312
| -96% | -$45.7M |
|
1788
FirstCash
FCFS
$9.16B
| $1.73M | ﹤0.01% |
19,753
-100
| -0.5% | -$8.27K |
|
1789
Park National Corp
PRK
$3.77B
| $1.73M | ﹤0.01% |
14,163
-210
| -1% | -$24.5K |
|
1790
Medifast
MED
$128M
| $1.73M | ﹤0.01% |
8,952
-1
| -0% | -$246 |
|
1791
Interactive Brokers
IBKR
$41.2B
| $1.72M | ﹤0.01% |
110,404
-5,452
| -5% | -$85.9K |
|
1792
Sprout Social
SPT
$601M
| $1.72M | ﹤0.01% |
14,093
+2,235
| +19% | +$243K |
|
1793
DigitalBridge
DBRG
$2.95B
| $1.69M | ﹤0.01% |
70,122
+3,425
| +5% | +$94.5K |
|
1794
TD Synnex
SNX
$20.4B
| $1.69M | ﹤0.01% |
16,225
-4,829
| -23% | -$577K |
|
1795
Fulton Financial
FULT
$4.72B
| $1.69M | ﹤0.01% |
110,395
-346
| -0.3% | -$5.36K |
|
1796
Neogen
NEOG
$2.59B
| $1.69M | ﹤0.01% |
38,834
-560
| -1% | -$24.4K |
|
1797
HEICO Corp
HEI
$52.1B
| $1.69M | ﹤0.01% |
12,780
+51
| +0.4% | +$6.72K |
|
1798
WD-40
WDFC
$3.1B
| $1.68M | ﹤0.01% |
7,264
-175
| -2% | -$42K |
|
|
ALLK
1799
DELISTED
Allakos
ALLK
| $1.67M | ﹤0.01% |
15,797
+872
| +6% | +$77.9K |
|
|
TWO
1800
Two Harbors Investment
TWO
$1.27B
| $1.67M | ﹤0.01% |
65,912
-7,317
| -10% | -$192K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.